| Literature DB >> 27516918 |
Piotr Seliger1, Danuta Tomczyk1, Grzegorz Andrijewski1, Ewa Tomal2.
Abstract
The protonation constants of new group of peptidomimetic cyclophanes with valine or phenylalanine moieties incorporated into the macrocyclic skeleton as well as their linear analogues were determined by potentiometric measurements in solutions of methanol-water mixtures at 25°C and constant ionic strength. The influence of cavity size, location of protonation sites, and attached substituents of the macrocyclic ligands on the protonation constants were discussed on the basis of potentiometric measurement as well as H(1)-NMR results.Entities:
Year: 2016 PMID: 27516918 PMCID: PMC4967707 DOI: 10.1155/2016/1721069
Source DB: PubMed Journal: J Anal Methods Chem ISSN: 2090-8873 Impact factor: 2.193
Scheme 1The schematic presentation of protonation of the investigated ligands.
Figure 1Structure of investigated linear ligands.
Logarithm values of successive protonation constants of LVal(n)a and LPhal(n)a in methanol-water solution x 0,95MeOH.
| Linear ligands | log | log |
|---|---|---|
| LVal4a | 8,44 ± 0,02 | 8,17 ± 0,02 |
| LVal3a | 8,17 ± 0,03 | 7,80 ± 0,03 |
| LVal2a | 8,14 ± 0,05 | 8,15 ± 0,03 |
| LPhal4a | 8,35 ± 0,02 | 7,86 ± 0,02 |
| LPhal3a | 8,11 ± 0,02 | 8,00 ± 0,01 |
| LPhal2a | 8,04 ± 0,04 | 7,82 ± 0,03 |
Figure 2Structures of investigated cyclic ligands.
Logarithm values of successive protonation constants CyPirVal(n)a, CyPirPhal(n)a, m-CyVal(n)a, and m-CyPhal(n)a in methanol-water solution x 0,1MeOH and x 0,95MeOH.
| Cyclic ligands |
|
| ||
|---|---|---|---|---|
| log | log | log | log | |
| CyPirVal4a | 6,56 ± 0,02 | 5,11 ± 0,02 | 7,38 ± 0,01 | 6,29 ± 0,01 |
| CyPirVal3a | 6,56 ± 0,02 | 5,40 ± 0,02 | 7,59 ± 0,01 | 6,50 ± 0,01 |
| CyPirVal2a | 6,37 ± 0,02 | 5,30 ± 0,02 | 7,57 ± 0,03 | 6,37 ± 0,03 |
| CyPirPhal4a | 6,18 ± 0,04 | 4,54 ± 0,05 | 7,31 ± 0,01 | 5,98 ± 0,01 |
| CyPirPhal3a | 6,24 ± 0,02 | 4,88 ± 0,03 | 7,23 ± 0,01 | 6,02 ± 0,01 |
| CyPirPhal2a | 6,15 ± 0,03 | 4,60 ± 0,03 | 7,13 ± 0,02 | 6,04 ± 0,02 |
| m-CyVal4a | 6,95 ± 0,03 | 5,53 ± 0,03 | 7,63 ± 0,02 | 6,18 ± 0,02 |
| m-CyVal3a | 6,91 ± 0,04 | 5,43 ± 0,04 | 7,99 ± 0,03 | 6,02 ± 0,04 |
| m-CyVal2a | 6,81 ± 0,03 | 5,57 ± 0,03 | 7,93 ± 0,04 | 5,73 ± 0,06 |
| m-CyPhal4a | —a | —a | 7,57 ± 0,03 | 5,67 ± 0,04 |
| m-CyPhal3a | —a | —a | 7,23 ± 0,05 | 5,97 ± 0,06 |
| m-CyPhal2a | —a | —a | 6,90 ± 0,06 | 6,05 ± 0,07 |
—a denotes that the lack of the protonation constants for m-CyPhal(n)a derivative is connected with the insufficient solubility of the ligand in the medium.
Figure 31H NMR spectrum of CyPirPhal4a in CD3OD.
Figure 41H NMR spectrum of CyPirVal3a in CD3OD.